Showing results (931-940 of 1,033) with videos related to

Sort By:
Pageof 104
The Lancet. Respiratory Medicine|May 15, 2026
Biological subphenotypes in severe acute hypoxaemic respiratory failure and acute respiratory distress syndrome using rapid prospective classification (SPARC) in the USA: a multicentre, observational, studyD Clark Files, Michael A Matthay, Andrew G Chapple, et al.
The Lancet. Respiratory Medicine|February 28, 2026
Medical thoracoscopy with talc poudrage and indwelling pleural catheter insertion versus medical thoracoscopy with talc poudrage alone for patients with symptomatic malignant pleural effusion (TACTIC): a randomised, controlled phase 3 trialAlexandra Dipper, Anand Sundaralingam, Emma Hedley, et al.
The Lancet. Respiratory Medicine|October 10, 2022
Effectiveness and durability of BNT162b2 vaccine against hospital and emergency department admissions due to SARS-CoV-2 omicron sub-lineages BA.1 and BA.2 in a large health system in the USA: a test-negative, case-control studySara Y Tartof, Jeff M Slezak, Laura Puzniak, et al.
The Lancet. Respiratory Medicine|December 20, 2016
Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysisEmily A Kendall, Anthony T Fojo, David W Dowdy
The Lancet. Respiratory Medicine|March 14, 2014
Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysisMichael H Cho, Merry-Lynn N McDonald, Xiaobo Zhou, et al.
The Lancet. Respiratory Medicine|April 11, 2014
Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosisKeertan Dheda, Tawanda Gumbo, Neel R Gandhi, et al.
The Lancet. Respiratory Medicine|April 11, 2014
Inhaled corticosteroids in children: effects on bone mineral density and growthAnne L Fuhlbrigge, H William Kelly
The Lancet. Respiratory Medicine|May 13, 2014
Genetic determinants of pulmonary fibrosis: evolving conceptsPaolo Spagnolo, Johan Grunewald, Roland M du Bois
The Lancet. Respiratory Medicine|April 22, 2014
Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind, placebo-controlled trialSevim Uzun, Remco S Djamin, Jan A J W Kluytmans, et al.
The Lancet. Respiratory Medicine|November 20, 2016
Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort studyMelissa J McDonnell, Stefano Aliberti, Pieter C Goeminne, et al.
Pageof 104